期刊文献+

两性霉素B平衡溶解度和表观油水分配系数的测定 被引量:7

Determination of equilibrium solubility of amphotericin B in various medium and its apparent oil/water partition coefficient
下载PDF
导出
摘要 目的测定两性霉素B在水和表面活性剂溶液中的平衡溶解度以及在正辛醇-水/缓冲液体系中的表观油水分配系数。方法采用高效液相色谱法测定了两性霉素B在水、缓冲液和表面活性剂溶液中的浓度,采用摇瓶法测定了两性霉素B的表观油水分配系数。结果37℃下两性霉素B在水中的平衡溶解度为31.97mg/L,在酸性和碱性缓冲液中溶解度增大;曲拉通-100(OP)对两性霉素B有较强的增溶能力;两性霉素B的表观油水分配系数为56.95。结论两性霉素B的水溶性较差,提高其口服制剂的溶出度可能会提高其生物利用度。 Objective To determine the equilibrium solubility of amphotericin B in various surfactant solutions and its partition coefficients for the n-octanol-water/buffer solution systems. Methods The high performance liquid chromatography (HPLC) method was established to detect the concentrations of amphotericin B in water, buffer solutions and surfactant solutions, and shaking flash method was used to determine the partition coefficients for the n-octanol-water/buffer solution systems of amphotedcin B. Results The equilibrium solubility of amphotericin B was 31.97 mg/L in water at 37 1Z, and increased in basic and acid buffer solutions. Triton X-100 (OP) was a good solubilizer for amphotericin B. The apparent oil/water partition coefficient of amphotedcin B was 56.95. Conclusion Amphotericin B is a slightly water-soluble drug. To increase the dissolution rate of amphotedcin B for its oral drug delivery system may enhance its bioavailability.
出处 《山西医科大学学报》 CAS 2007年第12期1082-1084,共3页 Journal of Shanxi Medical University
基金 山西省高校科技研究开发基金资助项目(200713008) 山西医科大学大学生创新基金资助项目(2006038)
关键词 色谱法 高压液相 两性霉素B 平衡溶解度 表观油水分配系数 chromatography, high pressure liquid amphotericin B equilibrium solubility apparent oil/water partition coefficient
  • 相关文献

参考文献7

二级参考文献47

  • 1吴终慧,雷招宝.伊曲康唑的不良反应[J].药物不良反应杂志,2004,6(3):166-169. 被引量:10
  • 2金有豫.抗真菌药[J].首都医药,2004,11(13):34-35. 被引量:5
  • 3王春英,郭会霞,宋丹.酮康唑致双下肢肌无力[J].临床误诊误治,2004,17(7):514-514. 被引量:4
  • 4Rondeau N, Bourcier T, Chaumeil C, et al. Fungal keratitis at the Centre Hospitalier National d' Ophtalmologie des Quinze-Vingts: retrospective study of 19 cases[J]. J Fr Ophtalmol, 2002, 25(9): 890-896.
  • 5Thomas PA. Current perspectives on ophthalmic mycoses[J]. Clin Microbiol Rev, 2003, 16(4): 730-797.
  • 6Kuriakose T, Kothari M, Paul P, et al. Intracameral amphotericin B injection in the management of deep keratomycosis[J]. Cornea, 2002, 21 (7):653-656.
  • 7Mora P, Bovey EH, Guex-Crosier Y. Mycotic endophthalmitis:management and treatment 9 year study[J]. Klin Monatsbl Augenheilkd, 2002, 219(4): 221-5.
  • 8Kaushik S, Ram J, Brar GS, et al. Intracameral amphotericin B: initial experience in severe keratomycosis[J]. Cornea, 2001,20(7): 715-719.
  • 9Sikic J, Vukojevic N, Katusic D, et al. Bilateral endogenous Candida endophthalmitis after induced abortion[J]. Croat Med J, 2001, 42(6):676-8.
  • 10Goldblum D, Rohrer K, Frueh BE, et al. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model[J].OphthalmicRec, 2004, 36(3): 172-176.

共引文献106

同被引文献44

引证文献7

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部